The novel treatment of the medication represents a significant development in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects multiple pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment